These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32712126)

  • 1. Molecular, physiological and behavioral characterization of the heterozygous Df[h15q13]/+ mouse model associated with the human 15q13.3 microdeletion syndrome.
    Rees KA; Halawa AA; Consuegra-Garcia D; Golub VM; Clossen BL; Tan AM; Montgomery KS; Samba Reddy D; Griffith WH; Winzer-Serhan UH
    Brain Res; 2020 Nov; 1746():147024. PubMed ID: 32712126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central and peripheral immune responses to low-dose lipopolysaccharide in a mouse model of the 15q13.3 microdeletion.
    Halawa AA; Rees KA; McCamy KM; Winzer-Serhan UH
    Cytokine; 2020 Feb; 126():154879. PubMed ID: 31629107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mouse model that recapitulates cardinal features of the 15q13.3 microdeletion syndrome including schizophrenia- and epilepsy-related alterations.
    Fejgin K; Nielsen J; Birknow MR; Bastlund JF; Nielsen V; Lauridsen JB; Stefansson H; Steinberg S; Sorensen HB; Mortensen TE; Larsen PH; Klewe IV; Rasmussen SV; Stefansson K; Werge TM; Kallunki P; Christensen KV; Didriksen M
    Biol Psychiatry; 2014 Jul; 76(2):128-37. PubMed ID: 24090792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral immune challenges elicit differential up-regulation of hippocampal cytokine and chemokine mRNA expression in a mouse model of the 15q13.3 microdeletion syndrome.
    McCamy KM; Rees KA; Winzer-Serhan UH
    Cytokine; 2022 Nov; 159():156005. PubMed ID: 36084604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 15q13.3 homozygous knockout mouse model display epilepsy-, autism- and schizophrenia-related phenotypes.
    Forsingdal A; Fejgin K; Nielsen V; Werge T; Nielsen J
    Transl Psychiatry; 2016 Jul; 6(7):e860. PubMed ID: 27459725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mouse model of the 15q13.3 microdeletion syndrome shows prefrontal neurophysiological dysfunctions and attentional impairment.
    Nilsson SRO; Celada P; Fejgin K; Thelin J; Nielsen J; Santana N; Heath CJ; Larsen PH; Nielsen V; Kent BA; Saksida LM; Stensbøl TB; Robbins TW; Bastlund JF; Bussey TJ; Artigas F; Didriksen M
    Psychopharmacology (Berl); 2016 Jun; 233(11):2151-2163. PubMed ID: 26983414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OTUD7A Regulates Neurodevelopmental Phenotypes in the 15q13.3 Microdeletion Syndrome.
    Uddin M; Unda BK; Kwan V; Holzapfel NT; White SH; Chalil L; Woodbury-Smith M; Ho KS; Harward E; Murtaza N; Dave B; Pellecchia G; D'Abate L; Nalpathamkalam T; Lamoureux S; Wei J; Speevak M; Stavropoulos J; Hope KJ; Doble BW; Nielsen J; Wassman ER; Scherer SW; Singh KK
    Am J Hum Genet; 2018 Feb; 102(2):278-295. PubMed ID: 29395074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse Model of Chromosome 15q13.3 Microdeletion Syndrome Demonstrates Features Related to Autism Spectrum Disorder.
    Kogan JH; Gross AK; Featherstone RE; Shin R; Chen Q; Heusner CL; Adachi M; Lin A; Walton NM; Miyoshi S; Miyake S; Tajinda K; Ito H; Siegel SJ; Matsumoto M
    J Neurosci; 2015 Dec; 35(49):16282-94. PubMed ID: 26658876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Df(h15q13)/+ Mouse Model Reveals Loss of Astrocytes and Synaptic-Related Changes of the Excitatory and Inhibitory Circuits in the Medial Prefrontal Cortex.
    Al-Absi AR; Qvist P; Glerup S; Sanchez C; Nyengaard JR
    Cereb Cortex; 2021 Feb; 31(3):1609-1621. PubMed ID: 33123721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An acetylcholine alpha7 positive allosteric modulator rescues a schizophrenia-associated brain endophenotype in the 15q13.3 microdeletion, encompassing CHRNA7.
    Gass N; Weber-Fahr W; Sartorius A; Becker R; Didriksen M; Stensbøl TB; Bastlund JF; Meyer-Lindenberg A; Schwarz AJ
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1150-60. PubMed ID: 27061851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice with mutations in Trpm1, a gene in the locus of 15q13.3 microdeletion syndrome, display pronounced hyperactivity and decreased anxiety-like behavior.
    Hori T; Ikuta S; Hattori S; Takao K; Miyakawa T; Koike C
    Mol Brain; 2021 Mar; 14(1):61. PubMed ID: 33785025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Otud7a Knockout Mice Recapitulate Many Neurological Features of 15q13.3 Microdeletion Syndrome.
    Yin J; Chen W; Chao ES; Soriano S; Wang L; Wang W; Cummock SE; Tao H; Pang K; Liu Z; Pereira FA; Samaco RC; Zoghbi HY; Xue M; Schaaf CP
    Am J Hum Genet; 2018 Feb; 102(2):296-308. PubMed ID: 29395075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound heterozygous microdeletion of chromosome 15q13.3 region in a child with hypotonia, impaired vision, and global developmental delay.
    Prasun P; Hankerd M; Kristofice M; Scussel L; Sivaswamy L; Ebrahim S
    Am J Med Genet A; 2014 Jul; 164A(7):1815-20. PubMed ID: 24700535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Vulnerable Interneuron Subtypes in 15q13.3 Microdeletion Syndrome Using Single-Cell Transcriptomics.
    Malwade S; Gasthaus J; Bellardita C; Andelic M; Moric B; Korshunova I; Kiehn O; Vasistha NA; Khodosevich K
    Biol Psychiatry; 2022 Apr; 91(8):727-739. PubMed ID: 34838304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The translationally relevant mouse model of the 15q13.3 microdeletion syndrome reveals deficits in neuronal spike firing matching clinical neurophysiological biomarkers seen in schizophrenia.
    Thelin J; Halje P; Nielsen J; Didriksen M; Petersson P; Bastlund JF
    Acta Physiol (Oxf); 2017 May; 220(1):124-136. PubMed ID: 27364459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 15q13.3 deletion syndrome: Deficient α(7)-containing nicotinic acetylcholine receptor-mediated neurotransmission in the pathogenesis of neurodevelopmental disorders.
    Deutsch SI; Burket JA; Benson AD; Urbano MR
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():109-17. PubMed ID: 26257138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of single gene deletions at 15q13.3: further evidence that CHRNA7 causes the 15q13.3 microdeletion syndrome phenotype.
    Hoppman-Chaney N; Wain K; Seger PR; Superneau DW; Hodge JC
    Clin Genet; 2013 Apr; 83(4):345-51. PubMed ID: 22775350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactive effects between hemizygous 15q13.3 microdeletion and peripubertal stress on adult behavioral functions.
    Giovanoli S; Werge TM; Mortensen PB; Didriksen M; Meyer U
    Neuropsychopharmacology; 2019 Mar; 44(4):703-710. PubMed ID: 30188511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Consequences of CHRNA7 Copy-Number Alterations in Induced Pluripotent Stem Cells and Neural Progenitor Cells.
    Gillentine MA; Yin J; Bajic A; Zhang P; Cummock S; Kim JJ; Schaaf CP
    Am J Hum Genet; 2017 Dec; 101(6):874-887. PubMed ID: 29129316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report of the first patient with a homozygous OTUD7A variant responsible for epileptic encephalopathy and related proteasome dysfunction.
    Garret P; Ebstein F; Delplancq G; Dozieres-Puyravel B; Boughalem A; Auvin S; Duffourd Y; Klafack S; Zieba BA; Mahmoudi S; Singh KK; Duplomb L; Thauvin-Robinet C; Costa JM; Krüger E; Trost D; Verloes A; Faivre L; Vitobello A
    Clin Genet; 2020 Apr; 97(4):567-575. PubMed ID: 31997314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.